Largest health care companies by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
UnitedHealth Group leads the 170 health care companies ranked by net assets, at SGD 129B, ahead of Pfizer (SGD 111.5B) and Johnson & Johnson (SGD 105.1B). Figures as of 19 Nov 2026, 10:12 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 170
- First
- UnitedHealth GroupSGD 129B
- Median
- SGD 3.3B
- Combined market value
- SGD 11.73T
- Countries
- 14
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | Net assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 101 | Kymera TherapeuticsKYMR · Health Care | SGD 2B | SGD 13.3B | SGD 156.16 | 0.32% down | 87% up | ||
| 102 | LifeStance Health GroupLFST · Health Care | SGD 2B | SGD 6.7B | SGD 17.75 | 2.82% down | 129% up | ||
| 103 | InsuletPODD · Health Care | SGD 2B | SGD 12.5B | SGD 180.46 | 3.69% down | 58% down | ||
| 104 | CencoraCOR · Health Care | SGD 1.9B | SGD 85.7B | SGD 449.04 | 0.64% down | 3% down | ||
| 105 | PenumbraPEN · Health Care | SGD 1.8B | SGD 16.3B | SGD 413.32 | 0.47% up | 13% up | ||
| 106 | MSA SafetyMSA · Health Care | SGD 1.8B | SGD 8.8B | SGD 228.77 | 2.67% up | 11% up | ||
| 107 | Option Care HealthOPCH · Health Care | SGD 1.7B | SGD 6.1B | SGD 40.88 | 0.25% up | 14% up | ||
| 108 | Krystal BiotechKRYS · Health Care | SGD 1.6B | SGD 12B | SGD 406.54 | 5.62% up | 46% up | ||
| 109 | LivaNovaLIVN · Health Care | SGD 1.5B | SGD 6.7B | SGD 121.88 | 2.85% up | 71% up | ||
| 110 | RadNetRDNT · Health Care | SGD 1.4B | SGD 7.3B | SGD 92.59 | 4.14% down | 7% down | ||
| 111 | Lantheus HoldingsLNTH · Health Care | SGD 1.4B | SGD 8.6B | SGD 131.50 | 0.20% up | 93% up | ||
| 112 | Ligand PharmaceuticalsLGND · Health Care | SGD 1.3B | SGD 7.7B | SGD 385.10 | 1.67% up | 43% up | ||
| 113 | Legend BiotechLEGN · Health Care | SGD 1.3B | SGD 4.1B | SGD 20.95 | 0.87% up | 42% down | ||
| 114 | ChemedCHE · Health Care | SGD 1.3B | SGD 9.1B | SGD 704.84 | 0.01% down | 27% up | ||
| 115 | Oscar HealthOSCR · Health Care | SGD 1.3B | SGD 11B | SGD 35.54 | 7.61% down | 112% up | ||
| 116 | PACS GroupPACS · Health Care | SGD 1.2B | SGD 9.5B | SGD 59.69 | 4.63% down | 188% up | ||
| 117 | Praxis Precision MedicinesPRAX · Health Care | SGD 1.1B | SGD 11B | SGD 393.45 | 0.04% up | 61% up | ||
| 118 | ImmunovantIMVT · Health Care | SGD 1.1B | SGD 8.8B | SGD 42.76 | 0.12% down | 43% up | ||
| 119 | 10x GenomicsTXG · Health Care | SGD 1B | SGD 9.7B | SGD 73.58 | 1.37% up | 260% up | ||
| 120 | HaemoneticsHAE · Health Care | SGD 1B | SGD 7.2B | SGD 158.39 | 1.60% up | 61% up | ||
| 121 | Alnylam PharmaceuticalsALNY · Health Care | SGD 1B | SGD 25.8B | SGD 192.61 | 4.54% down | 66% down | ||
| 122 | Belite BioBLTE · Health Care | SGD 993.3M | SGD 8.2B | SGD 201.41 | 0.94% down | 31% up | ||
| 123 | CG OncologyCGON · Health Care | SGD 970.3M | SGD 9.2B | SGD 103.14 | 1.34% up | 85% up | ||
| 124 | InsmedINSM · Health Care | SGD 952.7M | SGD 33.9B | SGD 154.45 | 1.69% down | 40% down | ||
| 125 | Spyre TherapeuticsSYRE · Health Care | SGD 922.1M | SGD 12.4B | SGD 130.80 | 8.15% up | 286% up | ||
| 126 | Summit TherapeuticsSMMT · Health Care | SGD 849.4M | SGD 10.8B | SGD 13.54 | 1.59% down | 36% down | ||
| 127 | GlaukosGKOS · Health Care | SGD 845.9M | SGD 17.8B | SGD 300.49 | 4.18% down | 152% up | ||
| 128 | TG TherapeuticsTGTX · Health Care | SGD 835.4M | SGD 12.9B | SGD 85.24 | 5.44% up | 107% up | ||
| 129 | Corcept TherapeuticsCORT · Health Care | SGD 835.2M | SGD 9.6B | SGD 87.40 | 3.25% down | 8% down | ||
| 130 | Cogent BiosciencesCOGT · Health Care | SGD 820.4M | SGD 6.2B | SGD 35.85 | 0.14% down | 20% down | ||
| 131 | Protagonist TherapeuticsPTGX · Health Care | SGD 792.5M | SGD 10.7B | SGD 163.94 | 2.00% up | 46% up | ||
| 132 | Madrigal PharmaceuticalsMDGL · Health Care | SGD 777M | SGD 11.9B | SGD 513.21 | 5.67% down | 24% down | ||
| 133 | Caris Life SciencesCAI · Health Care | SGD 744.3M | SGD 7.2B | SGD 25.14 | 2.21% down | 17% down | ||
| 134 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SGD 731.8M | SGD 9.6B | SGD 122.54 | 0.06% down | 126% up | ||
| 135 | Hims & Hers HealthHIMS · Health Care | SGD 697.4M | SGD 5.2B | SGD 21.98 | 2.85% down | 51% down | ||
| 136 | Edgewise TherapeuticsEWTX · Health Care | SGD 673.3M | SGD 5.8B | SGD 53.33 | 1.59% down | 88% up | ||
| 137 | ABIVAXABVX · Health Care | SGD 651.1M | SGD 9.5B | SGD 108.07 | 2.11% up | 27% down | ||
| 138 | Dianthus TherapeuticsDNTH · Health Care | SGD 636.1M | SGD 6.1B | SGD 108.27 | 3.45% down | 113% up | ||
| 139 | Ionis PharmaceuticalsIONS · Health Care | SGD 630.5M | SGD 5.9B | SGD 35.31 | 1.59% up | 64% down | ||
| 140 | BillionToOneBLLN · Health Care | SGD 619M | SGD 5.6B | SGD 118.01 | 6.11% down | 0% up | ||
| 141 | Twist BioscienceTWST · Health Care | SGD 609.7M | SGD 10.2B | SGD 150.00 | 3.88% up | 340% up | ||
| 142 | Oruka TherapeuticsORKA · Health Care | SGD 608.4M | SGD 8.4B | SGD 123.43 | 0.60% down | 241% up | ||
| 143 | Arrowhead PharmaceuticalsARWR · Health Care | SGD 600.8M | SGD 7.9B | SGD 55.58 | 0.28% up | 10% up | ||
| 144 | Medpace HoldingsMEDP · Health Care | SGD 591.8M | SGD 23.3B | SGD 833.95 | 0.95% down | 10% up | ||
| 145 | Concentra Group Holdings ParentCON · Health Care | SGD 507M | SGD 6.8B | SGD 54.12 | 0.94% down | 120% up | ||
| 146 | Definium TherapeuticsDFTX · Health Care | SGD 428.4M | SGD 5.1B | SGD 37.54 | 0.88% down | 169% up | ||
| 147 | ErascaERAS · Health Care | SGD 419.2M | SGD 6.2B | SGD 17.74 | 0.94% down | 403% up | ||
| 148 | Mirum PharmaceuticalsMIRM · Health Care | SGD 405.7M | SGD 7.8B | SGD 119.24 | 0.59% up | 31% up | ||
| 149 | HeartflowHTFL · Health Care | SGD 387.6M | SGD 5.2B | SGD 59.16 | 2.51% down | 73% up | ||
| 150 | Scholar Rock HoldingSRRK · Health Care | SGD 316.5M | SGD 7.5B | SGD 61.88 | 6.48% up | 14% up | ||
| 151 | Adaptive BiotechnologiesADPT · Health Care | SGD 282.1M | SGD 5.9B | SGD 36.69 | 0.11% down | 88% up | ||
| 152 | Kodiak SciencesKOD · Health Care | SGD 202.9M | SGD 8.2B | SGD 126.10 | 1.04% up | 396% up | ||
| 153 | Rhythm PharmaceuticalsRYTM · Health Care | SGD 179.3M | SGD 10.6B | SGD 153.47 | 2.08% up | 13% up | ||
| 154 | Travere TherapeuticsTVTX · Health Care | SGD 148M | SGD 6.2B | SGD 64.77 | 1.68% down | 44% up | ||
| 155 | Axsome TherapeuticsAXSM · Health Care | SGD 113.8M | SGD 9.1B | SGD 172.75 | 1.43% down | 7% down | ||
| 156 | Halozyme TherapeuticsHALO · Health Care | SGD 62.9M | SGD 14.1B | SGD 123.51 | 0.18% down | 37% up | ||
| 157 | Mettler-Toledo InternationalMTD · Health Care | -SGD 30.5M | SGD 44.5B | SGD 2,239.69 | 1.42% up | 22% up | ||
| 158 | Amneal PharmaceuticalsAMRX · Health Care | -SGD 91.3M | SGD 9.8B | SGD 28.21 | 3.60% up | 83% up | ||
| 159 | Guardant HealthGH · Health Care | -SGD 128M | SGD 25.3B | SGD 187.12 | 1.30% up | 44% up | ||
| 160 | VeradermicsMANE · Health Care | -SGD 156M | SGD 6.8B | SGD 160.97 | 0.62% down | 233% up | ||
| 161 | Ascendis PharmaASND · Health Care | -SGD 232.9M | SGD 22.9B | SGD 348.51 | 0.32% down | 28% up | ||
| 162 | PTC TherapeuticsPTCT · Health Care | -SGD 264.7M | SGD 6.5B | SGD 77.65 | 0.22% down | 20% down | ||
| 163 | ImmunityBioIBRX · Health Care | -SGD 645.2M | SGD 9.2B | SGD 8.64 | 7.03% up | 193% up | ||
| 164 | DaVitaDVA · Health Care | -SGD 839.4M | SGD 13.1B | SGD 208.58 | 6.48% down | 50% up | ||
| 165 | CytokineticsCYTK · Health Care | -SGD 850.4M | SGD 9.2B | SGD 66.16 | 0.64% down | 20% down | ||
| 166 | BridgeBio PharmaBBIO · Health Care | -SGD 2.7B | SGD 19.6B | SGD 100.57 | 1.58% up | 17% up | ||
| 167 | McKessonMCK · Health Care | -SGD 2.8B | SGD 161.4B | SGD 1,398.06 | 0.66% down | 28% up | ||
| 168 | Cardinal HealthCAH · Health Care | -SGD 3.7B | SGD 82.9B | SGD 358.81 | 0.33% down | 35% up | ||
| 169 | AbbVieABBV · Health Care | -SGD 4.2B | SGD 651.8B | SGD 368.73 | 2.33% down | 26% up | ||
| 170 | HCA HealthcareHCA · Health Care | -SGD 7.8B | SGD 128.3B | SGD 614.12 | 4.96% down | 4% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2892 SGD).
Questions and answers
Which health care companies rank first by net assets?
UnitedHealth Group (SGD 129B), Pfizer (SGD 111.5B) and Johnson & Johnson (SGD 105.1B) are the top three of the 170 health care companies ranked by net assets as of 19 Nov 2026, 10:12 UTC.
How many health care companies are in this ranking?
170 are ranked by net assets.
What are these health care companies worth together?
The 170 health care companies ranked by net assets have a combined market value of SGD 11.73T as of 19 Nov 2026, 10:12 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care companies by net assets”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.